Search Results - "Inoki L"

A Hybrid Retroperitoneal-Transperitoneal Approach for Robot-Assisted Radical Nephrectomy: A Technical Report of Two Cases.

Authors: Ohzeki T Mitsuhashi Y Inoki L et al.

Source: IJU case reports [IJU Case Rep] 2026 Jul 12; Vol. 9 (4), pp. e70226. Date of Electronic Publication: 2026 Jul 12 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: John Wiley & Sons Australia, Ltd Country of Publication: Australia NLM ID: 101764958 Publication Model: eCollection Cited Medium: Internet ISSN: 2577-171X (Electronic) Linking ISSN: 2577171X NLM ISO Abbreviation: IJU Case Rep Subsets: PubMed not MEDLINE

Impact of Proton Pump Inhibitor Use on the Efficacy of IO-IO Versus IO-TKI Therapy in Metastatic Renal Cell Carcinoma.

Authors: Inoki L Toyoda S Fukuokaya W et al.

Corporate Authors: Inoki L Toyoda S Fukuokaya W et al.

Source: Clinical genitourinary cancer [Clin Genitourin Cancer] 2026 Mar; Vol. 24 (2), pp. 102500. Date of Electronic Publication: 2026 Jan 03.

Publication Type: Journal Article; Multicenter Study; Comparative Study

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE

Differential impact of host-related factors on survival outcomes between IO+IO and IO+TKI in metastatic renal cell carcinoma: a multicenter retrospective study.

Authors: Sugimoto K Toyoda S Inoki L et al.

Corporate Authors: Sugimoto K Toyoda S Inoki L et al.

Source: International journal of clinical oncology [Int J Clin Oncol] 2026 Aug; Vol. 31 (8), pp. 1658-1667. Date of Electronic Publication: 2026 Jun 11.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE

Timing-dependent skin toxicity phenotypes during enfortumab vedotin plus pembrolizumab therapy for advanced urothelial carcinoma.

Authors: Hashimoto M Inoki L Yamamoto Y et al.

Corporate Authors: Hashimoto M Inoki L Yamamoto Y et al.

Source: International journal of clinical oncology [Int J Clin Oncol] 2026 Jul 27. Date of Electronic Publication: 2026 Jul 27.

Publication Type: Journal Article

Journal Info: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE

Real-world safety and effectiveness of enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma: A multicenter Japanese cohort study.

Authors: Yanagisawa T Iwatani K Urabe F et al.

Corporate Authors: Yanagisawa T Iwatani K Urabe F et al.

Source: Urologic oncology [Urol Oncol] 2026 Jul 17. Date of Electronic Publication: 2026 Jul 17.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 9805460 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2496 (Electronic) Linking ISSN: 10781439 NLM ISO Abbreviation: Urol Oncol Subsets: MEDLINE

Development of a prognostic model for elderly patients with metastatic clear cell renal cell carcinoma treated with first-line immuno-oncology combination therapy.

Authors: Watanabe S Matsushita Y Oishi Y et al.

Corporate Authors: Watanabe S Matsushita Y Oishi Y et al.

Source: Japanese journal of clinical oncology [Jpn J Clin Oncol] 2026 May 17. Date of Electronic Publication: 2026 May 17.

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0313225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1465-3621 (Electronic) Linking ISSN: 03682811 NLM ISO Abbreviation: Jpn J Clin Oncol Subsets: MEDLINE

Comparative efficacy of immune checkpoint inhibitor combination therapies by metastatic site in metastatic renal cell carcinoma.

Authors: Toyoda S Inoki L Hashimoto M et al.

Corporate Authors: Toyoda S Inoki L Hashimoto M et al.

Source: Scientific reports [Sci Rep] 2026 Jan 13; Vol. 16 (1), pp. 3303. Date of Electronic Publication: 2026 Jan 13.

Publication Type: Clinical Study; Comparative Study; Journal Article; Multicenter Study

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Predictors of early progressive disease and antitumor effects by metastatic site in renal cell carcinoma treated with ipilimumab plus nivolumab.

Authors: Mori K Yanagisawa T Kawada T et al.

Source: International journal of clinical oncology [Int J Clin Oncol] 2025 Nov; Vol. 30 (11), pp. 2335-2341. Date of Electronic Publication: 2025 Sep 05.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE

Role of Cytoreductive Nephrectomy in the Immune Checkpoint Inhibitor Era: A Multicenter Collaborative Study.

Authors: Nukaya T Takahara K Toyoda S et al.

Source: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2025 Nov; Vol. 32 (11), pp. 1677-1685. Date of Electronic Publication: 2025 Aug 19.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 9440237 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1442-2042 (Electronic) Linking ISSN: 09198172 NLM ISO Abbreviation: Int J Urol Subsets: MEDLINE

Rash and Endocrine Disorders Predict Improved Survival in Metastatic Renal Cell Carcinoma Treated With Immunotherapy.

Authors: Sugimoto K Minami T Toyoda S et al.

Corporate Authors: Sugimoto K Minami T Toyoda S et al.

Source: Anticancer research [Anticancer Res] 2025 Aug; Vol. 45 (8), pp. 3355-3364.

Publication Type: Journal Article

Journal Info: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

Eosinophils as a predictive marker of treatment-related adverse events in mRCC patients treated with first-line immune-checkpoint inhibitor combination therapy.

Authors: Kawada T Katayama S Yanagisawa T et al.

Corporate Authors: Kawada T Katayama S Yanagisawa T et al.

Source: Scientific reports [Sci Rep] 2025 Jul 25; Vol. 15 (1), pp. 27163. Date of Electronic Publication: 2025 Jul 25.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE